Covalab is a biotechnology company that specializes in antibody engineering. It designs and develops antibodies, including polyclonal, monoclonal scFv, FAb, VHH, and recombinant antibodies, using antigen or DNA immunization. In addition, the company offers purified and labeling antibodies as well as peptide synthesis for research, diagnostic, and therapeutic use.